Biodistribution of indocyanine green-loaded nanoparticles with surface modifications of PEG and folic acid

被引:65
作者
Ma, Ying [1 ]
Sadoqi, Mostafa
Shao, Jun [1 ]
机构
[1] St Johns Univ, Coll Pharm & Allied Hlth Profess, Dept Pharmaceut Sci, Biotechnol & Drug Delivery Lab, Queens, NY 11439 USA
关键词
Indocyanine green (ICG); Folic acid; Folate-receptor (FR) targeted; PEG; Biodistribution; Breast cancer; PLGA-MPEG NANOPARTICLES; TUMOR-BEARING MICE; VASCULAR-PERMEABILITY; PHOTODYNAMIC THERAPY; FOLATE RECEPTOR; DRUG-DELIVERY; LIPOSOMES; CANCER; LIPOSOMALIZATION; THERAPEUTICS;
D O I
10.1016/j.ijpharm.2012.06.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose: To establish the biodistribution profile of the PLGA nanoparticles with dual surface modifications of PEG and folic acid (FA) in mice xenografted with MDA-MB-231 human breast cancer cells with high expression of folate receptor (FR); and to illustrate that the modified nanoparticles can target the loaded indocyanine green (ICG) to the tumor with high FR expression. Methods: ICG-loaded nanoparticles were prepared with PLGA (non-modified nanoparticles, NM-NP) or mPEG-PLGA and FA-PLGA (dual modified nanoparticles, DM-NP). Biodistribution of the ICG-loaded nanoparticles (1.25 mg/kg) after i.v. injection was investigated on athymic mice transplanted with MDA-MB-231 tumor. Results: ICG concentration in plasma from the DM-NP group was significantly (p < 0.05) higher than the NM-NP group from 90 min to the end of the study (12 h). After 4 h, the drug concentration in the tumor tissue from the DM-NP started to be significantly (p < 0.05) higher than the NM-NP until 12 h. Compared to the NM-NP, the DM-NP increased the AUC(0-12h) in plasma by 245% and the AUC(0-12h) in tumor by 194%, while decreased the AUC(0-12h) in liver by 13%. Conclusion: The accumulation of DM-NP into the tumor was significantly higher than NM-NP due to the long circulation and FR-mediated uptake. (c) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:25 / 31
页数:7
相关论文
共 35 条
[1]   Design and synthesis of 99mTc-citro-folate for use as a tumor-targeted radiopharmaceutical [J].
Altiparmak, Burcu ;
Lambrecht, Fatma Yurt ;
Bayrak, Elif ;
Durkan, Kubra .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 400 (1-2) :8-14
[2]   Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles [J].
Avgoustakis, K ;
Beletsi, A ;
Panagi, Z ;
Klepetsanis, P ;
Livaniou, E ;
Evangelatos, G ;
Ithakissios, DS .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 259 (1-2) :115-127
[3]   PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in Vivo drug residence in blood properties [J].
Avgoustakis, K ;
Beletsi, A ;
Panagi, Z ;
Klepetsanis, P ;
Karydas, AG ;
Ithakissios, DS .
JOURNAL OF CONTROLLED RELEASE, 2002, 79 (1-3) :123-135
[4]   Nanoparticles in cancer therapy and diagnosis [J].
Brigger, I ;
Dubernet, C ;
Couvreur, P .
ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (05) :631-651
[5]   Biodistribution, pharmacokinetics and imaging of 188Re-BMEDA-labeled pegylated liposomes after intraperitoneal injection in a C26 colon carcinoma ascites mouse model [J].
Chen, Liang-Cheng ;
Chang, Chih-Hsien ;
Yu, Chia-Yu ;
Chang, Ya-Jane ;
Hsu, Wei-Chuan ;
Ho, Chung-Li ;
Yeh, Chung-Hsin ;
Luo, Tsai-Yueh ;
Lee, Te-Wei ;
Ting, Gann .
NUCLEAR MEDICINE AND BIOLOGY, 2007, 34 (04) :415-423
[6]   INDOCYANINE GREEN - OBSERVATIONS ON ITS PHYSICAL PROPERTIES, PLASMA DECAY, AND HEPATIC EXTRACTION [J].
CHERRICK, GR ;
STEIN, SW ;
LEEVY, CM ;
DAVIDSON, CS .
JOURNAL OF CLINICAL INVESTIGATION, 1960, 39 (04) :592-600
[7]   Fluorescence properties and metabolic features of indocyanine green (ICG) as related to angiography [J].
Desmettre, T ;
Devoisselle, JM ;
Mordon, S .
SURVEY OF OPHTHALMOLOGY, 2000, 45 (01) :15-27
[8]  
ELWOOD PC, 1989, J BIOL CHEM, V264, P14893
[9]   In vivo near-infrared fluorescence imaging [J].
Frangioni, JV .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2003, 7 (05) :626-634
[10]  
Gabizon A, 2003, CLIN CANCER RES, V9, P6551